|1.||Martins, José Luiz: 2 articles (03/2012 - 11/2007)|
|2.||Lemos, Patrícia Veruska Ribeiro Barbosa: 1 article (03/2012)|
|3.||Silva Júnior, Valdemiro Amaro da: 1 article (03/2012)|
|4.||Santos, Fernando Leandro dos: 1 article (03/2012)|
|5.||Lemos, Sidney Pereira Pinto: 1 article (03/2012)|
|6.||Silva, Silvio Romero Gonçalves e: 1 article (03/2012)|
|7.||Meyer, Karine Furtado: 1 article (11/2007)|
|8.||Macedo, Maurício: 1 article (11/2007)|
|9.||Soares, Iberê Cauduro: 1 article (11/2007)|
|10.||Hartmann, Sabine: 1 article (07/2006)|
|2.||Ganglion Cysts (Ganglion)
03/01/1989 - "Embryos were studied either after direct exposure to ethylenethiourea (ETU) during incubation of embryo cultures or after maternal ETU dosing and subsequent embryonic development in utero with a view to assess the similarity of these two systems to produce hydrocephalus. "
03/01/1989 - "Ethylenethiourea-induced hydrocephalus in vivo and in vitro with a note on the use of a constant gaseous atmosphere for rat embryo cultures."
01/01/1987 - "Ethylenethiourea (ETU) is a specific neuroteratogen that induces communicating hydrocephalus ex vacuo at oral doses far lower than those that cause any observable toxic sign or 50% death (LD50) in the rat dam. "
10/01/1977 - "Ethylenethiourea-induced hydrocephalus: pre- and postnatal pathogenesis in offspring from rats given a single oral dose during pregnancy."
01/01/1980 - "Comparative studies of the carcinogenic activity of procarbazine, methylphenylnitrosourea and ethylenethiourea after transplacental and postnatal administration showed that there were marked differences in frequency and spectrum of tumors induced. "
01/01/1993 - "Tumor induction by concurrent oral administration of ethylenethiourea and sodium nitrite in mice."
|5.||Body Weight (Weight, Body)
08/01/1996 - "A positive control group of 15 dams received daily oral doses of 85 mg ethylenethiourea (ETU)/kg body weight on gestation days 11, 12, and 13; positive control dams received no MF exposure. "
07/01/1990 - "Twenty-eight pregnant rats (Wistar-Imamichi) on the 11th gestation day were treated with a single intragastric administration of ethylenethiourea (ETU) of 100, 125, 150, and 200 mg/kg body weight, and received cesarean section on the 20th gestation day. "
|1.||Urethane (Ethyl Carbamate)
|5.||Messenger RNA (mRNA)
|2.||Cesarean Section (Caesarean Section)